BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment

1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3. To establish how much the BMI must be reduced to cure this disease. 4. To assess the evolution and response to treatments of sick people who DO NOT reduce or even continue to increase their BMI despite treatment with Acetazolamide or a possible CSF diversion

NCT Number	NCT06913712
Lead Sponsor	University of Valencia
Conditions	Idiopathic Intracranial Hypertension (IIH)
Enrollment	25 participants
Start Date	2024-06-27
Primary Completion	2028-05-01 (estimated)
Study Completion	2028-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-22